LabCorp Venture Fund
Operating Status: Operating
NC-based LabCorp Venture Fund invests in early-stage health solutions, co-investing $500K-$2M initially, with up to $5M follow-on.
NC-based LabCorp Venture Fund invests in early-stage health solutions, co-investing $500K-$2M initially, with up to $5M follow-on.
labcorp.comCrawled Oct 16, 2026
The page lists genes included in Labcorp Carrier Screen panels and lets users search for a gene or disorder to see which panels include it.
The article discusses how clinicians can gain relevant insights from complex data for concise decision support at the point of care. It is by Jennifer Ennis, MD, associate vice president and medical director.
The U.S. Environmental Protection Agency has revised its regulatory approaches for biopesticides and has a dedicated division, the Biopesticides and Pollution Prevention Division. The page compares this approach with that of the European Union.
Labcorp’s Global Supply Chain Sourcing and Procurement team has reconfigured manufacturer relationships and developed processes to identify and qualify alternative supplies for customized clinical trial kits amid global supply disruptions.
The company is expanding its capacity for genetic toxicology and in vitro alternatives to help address changing regulatory requirements and support research based on the 3Rs: replacement, reduction and refinement.
Labcorp is a global life sciences and healthcare company whose mission is to improve health and lives.
The page lists Labcorp’s headquarters address, ticker symbol and media contacts.
Labcorp has more than 67,000 employees in nearly 100 countries. Its patient service centers and performing lab facilities support lab collection and testing processes.
Labcorp’s help center provides frequently asked questions, contact information and resources for lab questions.
Labcorp helps patients, providers, organizations, and biopharma companies to guide vital healthcare decisions each and every day.
Evvy raises $40 million in Series B funding to scale its precision diagnostics and care platform for women’s health. Its at-home vaginal microbiome test uses metagenomic sequencing, while EvvyAI analyzes results and matches patients with personalized prescription treatment plans. The company says its technology has served more than 100,000 patients through 3,000 medical practitioners, and it plans to use the funding to validate AI-enabled care models, starting with fertility issues.
Sep 2026 · SiliconAngleNews article